bioAffinity Technologies (BIAF) Operating Income (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Operating Income of -$3.6 million for Q1 2026, down 37.68% year-over-year from -$5.8 million in Q1 2025, and down 15.3% quarter-over-quarter from -$3.1 million in Q4 2025.
bioAffinity Technologies (BIAF) Operating Income (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Operating Income for 6 consecutive years, with -$3.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 37.68% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at -$11.6 million (down 20.0% YoY), while the FY2025 annual figure was -$10.6 million, down 18.08% from the prior year.
- Operating Income eased to -$3.6 million in Q1 2026 per BIAF's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Operating Income topped out at -$684119.0 in Q2 2022 and bottomed at -$3.6 million in Q1 2026.
- Historically, Operating Income has averaged -$2.1 million across 5 years, with a median of -$2.1 million in 2024.
- Annual changes were most pronounced in 2023 — Operating Income slumped 159.95% — and 2024, when it gained 13.97%.
- bioAffinity Technologies' Operating Income stood at -$1.6 million in 2022, then tumbled by 44.26% to -$2.3 million in 2023, then decreased by 25.79% to -$2.9 million in 2024, then slipped by 6.46% to -$3.1 million in 2025, then fell by 15.3% to -$3.6 million in 2026.
- Business Quant data shows BIAF's Operating Income at -$3.6 million in Q1 2026, -$3.1 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 2.09 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 1.13 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -75.79 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 399.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 506.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 425.57 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 245.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 328.45 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 451.60 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | -3.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.33 Mn |
| Mar 31, 2026 | -3.62 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -2.29 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Mar 31, 2025 | -2.63 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -2.09 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | -2.34 Mn |
| Sep 30, 2023 | -2.29 Mn |
| Jun 30, 2023 | -1.78 Mn |
| Mar 31, 2023 | -1.56 Mn |
| Dec 31, 2022 | -1.62 Mn |
| Sep 30, 2022 | -976,156.00 |
| Jun 30, 2022 | -684,119.00 |
| Mar 31, 2022 | -727,043.00 |
| Dec 31, 2021 | -659,752.00 |
| Sep 30, 2021 | -526,293.00 |